CM
UBX

Cercano Management’s Unity Biotechnology UBX Stock Holding History

Cercano Management’s Portfolio UBX Stock Details UBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-41,238
Closed -$42.9K – 175
2025
Q1 		$42.9K Hold
41,238
– – ﹤0.01% 148
2024
Q4 		$40.3K Hold
41,238
– – ﹤0.01% 177
2024
Q3 		$60.6K Hold
41,238
– – ﹤0.01% 156
2024
Q2 		$55.7K Hold
41,238
– – ﹤0.01% 98
2024
Q1 		$67.6K Hold
41,238
– – ﹤0.01% 101
2023
Q4 		$79.6K Hold
41,238
– – ﹤0.01% 93
2023
Q3 		$99K Hold
41,238
– – ﹤0.01% 102
2023
Q2 		$105K Hold
41,238
– – ﹤0.01% 107
2023
Q1 		$67.2K Hold
41,238
– – ﹤0.01% 112
2022
Q4 		$113K Buy
+41,238
New +$120K ﹤0.01% 112

Other funds holding UBX

AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
FFVM
Founders Fund V Management San Francisco, California $2.16M AUM 77.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cercano Management's UBX Position: Q2 2025 in Review

Cercano Management sold out of Unity Biotechnology (UBX) in Q2 2025, closing a stake of 41,238 shares — an estimated $42.9K sold.

Cercano Management first reported a position in UBX in Q4 2022 and held it in 10 quarters. The position peaked at $113K in Q4 2022. 35 funds tracked by Wall St. Rank hold UBX as of Q2 2025.

  • Cercano Management reported no remaining Unity Biotechnology position as of Q2 2025 after selling out during the quarter.
  • Cercano Management sold 41,238 Unity Biotechnology shares in Q2 2025, an estimated $42.9K.
  • Cercano Management first reported a position in Unity Biotechnology in Q4 2022 and held it in 10 quarters.
  • Cercano Management's Unity Biotechnology position peaked at $113K in Q4 2022.
  • 35 funds tracked by Wall St. Rank held Unity Biotechnology as of Q2 2025.

Based on Cercano Management's 13F filing for Q2 2025, filed 8 Aug 2025.